We found that all 6 genes had higher expression in the AD cases than in the controls, with all but 1 (ANGPT2, p = 0.066) reaching significance, thus validating our prior findings in the snRNAseq data (Supplementary Fig. 12A, Supplementary Data 27). This evidence concerns the gene ANGPT2 and Alzheimer disease.